Pacira BioSciences Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$179,516	$181,099	$168,923	$187,253
Gross Profit	145,238	140,233	134,617	147,367
EBITDA	34,368	29,241	33,609	50,603
EBIT	13,177	1,919	12,441	29,360
Net Income	5,432	-4,847	4,812	16,041
Net Change In Cash	179,516	181,099	168,923	187,253
Free Cash Flow	56,964	9,315	26,911	31,014
Cash	147,589	300,484	283,610	276,774
Basic Shares	44,459	45,459	46,526	49,036

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$700,966	$674,978	$666,823	$541,533
Gross Profit	530,538	490,309	467,528	401,278
EBITDA	29,118	154,585	140,379	113,948
EBIT	-49,667	79,011	48,878	85,400
Net Income	-99,560	41,955	15,909	41,980
Net Change In Cash	700,966	674,978	666,823	541,533
Cost of Revenue				485,621
Free Cash Flow	178,753	139,488	115,198	79,851
Cash	276,774	153,298	104,139	585,578
Basic Shares	46,245	51,979	46,538	45,630